Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
JEF Clear Quant Ltd JEF AI Quantitative Trading
New AI Companion App Aims to Offer a Friendly Voice Amid Growing Loneliness Epidemic
Sephora Wants in on Serious Skincare. Medik8 Provides an Answer.
Ukraine’s outgoing defence minister attacks Zelenskyy as thousands protest against firing
The best eye masks to help you sleep all summer – tested in a UK heatwave
Westren Capital Broadens Trading Strategy With Entry Into Prediction Markets
Alpaca raises $135M to fund tokenized agent-first infrastructure
Gambling on random Pokémon cards: Onchain gagcha hits record high as crypto sinks
Chanel CFO Philippe Blondiaux to Retire at Year’s End
Claudia Winkleman quits chat show after one series
XPeng’s New ‘Budget’ EV Looks Like the Ferrari Luce
11 Best Sleeping Bags (2026): Ultralight, Warm Weather, for Kids
A&O Shearman hands partners £2.2mn as profits return to pre-merger levels
24m tune in to watch England-Argentina
CASA LAWA brings cult design-led dining experience to Rondo with Monkey Shoulder
Modon Holding and Nammos Hotels & Resorts bring Nammos Ras El Hekma to Egypt’s North Coast
Chop, chop! My favourite fridge-raid dinner, no-cook meals and super salads
Move Over Shakespeare, This Husband Just Wrote 200 Poems About His Wife and Lived to Tell the Tale
Referent Launches AI-Native Legal Practice Management Platform as Solo Lawyers Lose Up to 15 Hours a Week Before Billing a Single Minute
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute